Thread by @jonworth

* Very tentative conclusions on Janssen / Johnson & Johnson vaccine supply *

It looks like EU legitimately feared a UK/AstraZeneca situation with USA for J&J - that vaccine produce in NL and finished in USA would be prevented from leaving back to EU

But two things have happened

First, J&J supply issues in the USA have not been fully solved, especially finishing
npr.org/sections/healt…
(thanks @el_snoop)

Second, EU countries together with Janssen and J&J, have found ways to do finishing (and even step up production) in the EU

At Reig Jofre 🇪🇸
reuters.com/article/idUSKB…

And IDT Biologika 🇩🇪 (temporarily)
idt-biologika.com/idt-biologika-…

Breton even went to visit Reig Jofre last week:

https://twitter.com/ThierryBreton/status/1375432895888830465

Thanks @TWPieterse @arekmakarenko @cymro69 @s_cortenraad @inwiii for help understanding these parts of the story

Yes, the EU is going to get a bit of a delay with its J&J shipments, but given the situation in the supply chain this is probably to be expected
politico.eu/article/despit…

So - very tentatively - it looks like EU-USA-J&J is not going to go the way of EU-UK-AZ

There probably a bit of luck, a bit of learning, and a bit of J&J being better in their comms than AZ in this

But having researched this, I am more reassured than I was

/ends

P.S: Via @AuerSusan, it seems J&J itself realised the problem and sought alternative locations for finishing merkur.de/welt/corona-im…